Titre : Dermatoses vasculaires

Dermatoses vasculaires : Questions médicales fréquentes

Termes MeSH sélectionnés :

Quantitative Structure-Activity Relationship
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Dermatoses vasculaires : Questions médicales les plus fréquentes", "headline": "Dermatoses vasculaires : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Dermatoses vasculaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-11", "dateModified": "2025-03-06", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Dermatoses vasculaires" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies de la peau", "url": "https://questionsmedicales.fr/mesh/D012871", "about": { "@type": "MedicalCondition", "name": "Maladies de la peau", "code": { "@type": "MedicalCode", "code": "D012871", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C17.800" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Angiomatose bacillaire", "alternateName": "Angiomatosis, Bacillary", "url": "https://questionsmedicales.fr/mesh/D016917", "about": { "@type": "MedicalCondition", "name": "Angiomatose bacillaire", "code": { "@type": "MedicalCode", "code": "D016917", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C17.800.862.060" } } }, { "@type": "MedicalWebPage", "name": "Maladie de Behçet", "alternateName": "Behcet Syndrome", "url": "https://questionsmedicales.fr/mesh/D001528", "about": { "@type": "MedicalCondition", "name": "Maladie de Behçet", "code": { "@type": "MedicalCode", "code": "D001528", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C17.800.862.150" } } }, { "@type": "MedicalWebPage", "name": "Vasculopathie livédoïde", "alternateName": "Livedoid Vasculopathy", "url": "https://questionsmedicales.fr/mesh/D000090122", "about": { "@type": "MedicalCondition", "name": "Vasculopathie livédoïde", "code": { "@type": "MedicalCode", "code": "D000090122", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C17.800.862.406" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Maladie de Raynaud", "alternateName": "Raynaud Disease", "url": "https://questionsmedicales.fr/mesh/D011928", "about": { "@type": "MedicalCondition", "name": "Maladie de Raynaud", "code": { "@type": "MedicalCode", "code": "D011928", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C17.800.862.406.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Papulose atrophiante maligne", "alternateName": "Malignant Atrophic Papulosis", "url": "https://questionsmedicales.fr/mesh/D054853", "about": { "@type": "MedicalCondition", "name": "Papulose atrophiante maligne", "code": { "@type": "MedicalCode", "code": "D054853", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C17.800.862.457" } } }, { "@type": "MedicalWebPage", "name": "Maladie de Kawasaki", "alternateName": "Mucocutaneous Lymph Node Syndrome", "url": "https://questionsmedicales.fr/mesh/D009080", "about": { "@type": "MedicalCondition", "name": "Maladie de Kawasaki", "code": { "@type": "MedicalCode", "code": "D009080", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C17.800.862.560" } } }, { "@type": "MedicalWebPage", "name": "Polyartérite noueuse", "alternateName": "Polyarteritis Nodosa", "url": "https://questionsmedicales.fr/mesh/D010488", "about": { "@type": "MedicalCondition", "name": "Polyartérite noueuse", "code": { "@type": "MedicalCode", "code": "D010488", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C17.800.862.625" } } }, { "@type": "MedicalWebPage", "name": "Syndrome de Sneddon", "alternateName": "Sneddon Syndrome", "url": "https://questionsmedicales.fr/mesh/D018860", "about": { "@type": "MedicalCondition", "name": "Syndrome de Sneddon", "code": { "@type": "MedicalCode", "code": "D018860", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C17.800.862.775" } } }, { "@type": "MedicalWebPage", "name": "Maladie de Takayashu", "alternateName": "Takayasu Arteritis", "url": "https://questionsmedicales.fr/mesh/D013625", "about": { "@type": "MedicalCondition", "name": "Maladie de Takayashu", "code": { "@type": "MedicalCode", "code": "D013625", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C17.800.862.875" } } } ], "about": { "@type": "MedicalCondition", "name": "Dermatoses vasculaires", "alternateName": "Skin Diseases, Vascular", "code": { "@type": "MedicalCode", "code": "D017445", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Thomas Mentzel", "url": "https://questionsmedicales.fr/author/Thomas%20Mentzel", "affiliation": { "@type": "Organization", "name": "Pathologist, Dermatopathology Department, Dermatopathologie Bodensee, Friedrichshafen, Germany; and." } }, { "@type": "Person", "name": "Martina M Sanchez", "url": "https://questionsmedicales.fr/author/Martina%20M%20Sanchez", "affiliation": { "@type": "Organization", "name": "Departments of Bioengineering, University of California." } }, { "@type": "Person", "name": "Joshua T Morgan", "url": "https://questionsmedicales.fr/author/Joshua%20T%20Morgan", "affiliation": { "@type": "Organization", "name": "Departments of Bioengineering, University of California; jmorgan@engr.ucr.edu." } }, { "@type": "Person", "name": "Hans-Uwe Simon", "url": "https://questionsmedicales.fr/author/Hans-Uwe%20Simon", "affiliation": { "@type": "Organization", "name": "Institute of Pharmacology, University of Bern, Bern, Switzerland." } }, { "@type": "Person", "name": "Dagmar Simon", "url": "https://questionsmedicales.fr/author/Dagmar%20Simon", "affiliation": { "@type": "Organization", "name": "Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. dagmar.simon@insel.ch." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Design, Synthesis, Antibacterial Evaluation, Three-Dimensional Quantitative Structure-Activity Relationship, and Mechanism of Novel Quinazolinone Derivatives.", "datePublished": "2023-02-21", "url": "https://questionsmedicales.fr/article/36807581", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.jafc.2c07264" } }, { "@type": "ScholarlyArticle", "name": "Automated machine learning approach for developing a quantitative structure-activity relationship model for cardiac steroid inhibition of Na", "datePublished": "2023-06-24", "url": "https://questionsmedicales.fr/article/37354314", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s43440-023-00508-x" } }, { "@type": "ScholarlyArticle", "name": "Multivariate image analysis applied to quantitative structure-activity relationships and docking studies of recent hydroxyphenylpyruvate deoxygenase inhibitors.", "datePublished": "2023-04-18", "url": "https://questionsmedicales.fr/article/37021557", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jsfa.12608" } }, { "@type": "ScholarlyArticle", "name": "Artificial Intelligence-Based Quantitative Structure-Property Relationship Model for Predicting Human Intestinal Absorption of Compounds with Serotonergic Activity.", "datePublished": "2023-04-18", "url": "https://questionsmedicales.fr/article/37070956", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.molpharmaceut.2c01117" } }, { "@type": "ScholarlyArticle", "name": "Development of a quantitative structure-activity relationship model for predicting quantum yield of hydroxyl radical generation from organic compounds.", "datePublished": "2023-01-25", "url": "https://questionsmedicales.fr/article/36504232", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1039/d2em00396a" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies de la peau et du tissu conjonctif", "item": "https://questionsmedicales.fr/mesh/D017437" }, { "@type": "ListItem", "position": 3, "name": "Maladies de la peau", "item": "https://questionsmedicales.fr/mesh/D012871" }, { "@type": "ListItem", "position": 4, "name": "Dermatoses vasculaires", "item": "https://questionsmedicales.fr/mesh/D017445" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Dermatoses vasculaires - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Dermatoses vasculaires", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Dermatoses vasculaires", "description": "Comment diagnostique-t-on une dermatoses vasculaire ?\nQuels tests sont utilisés pour évaluer les dermatoses vasculaires ?\nLes dermatoses vasculaires nécessitent-elles des examens sanguins ?\nQuels signes cliniques indiquent une dermatoses vasculaire ?\nPeut-on confondre les dermatoses vasculaires avec d'autres maladies ?", "url": "https://questionsmedicales.fr/mesh/D017445?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Dermatoses vasculaires", "description": "Quels sont les symptômes courants des dermatoses vasculaires ?\nLes dermatoses vasculaires provoquent-elles des douleurs ?\nLes dermatoses vasculaires peuvent-elles causer des saignements ?\nY a-t-il des symptômes systémiques associés ?\nLes démangeaisons sont-elles fréquentes ?", "url": "https://questionsmedicales.fr/mesh/D017445?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Dermatoses vasculaires", "description": "Comment prévenir les dermatoses vasculaires ?\nL'hydratation de la peau est-elle importante ?\nLes vêtements peuvent-ils aider à prévenir ces affections ?\nFaut-il éviter certains aliments ?\nLe stress influence-t-il les dermatoses vasculaires ?", "url": "https://questionsmedicales.fr/mesh/D017445?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Dermatoses vasculaires", "description": "Quels traitements sont disponibles pour les dermatoses vasculaires ?\nLes corticostéroïdes sont-ils efficaces ?\nQuand faut-il envisager une intervention chirurgicale ?\nLes traitements naturels sont-ils recommandés ?\nLes lasers sont-ils efficaces pour traiter ces affections ?", "url": "https://questionsmedicales.fr/mesh/D017445?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Dermatoses vasculaires", "description": "Quelles complications peuvent survenir ?\nLes dermatoses vasculaires peuvent-elles affecter la qualité de vie ?\nY a-t-il un risque de cancer associé ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications ?", "url": "https://questionsmedicales.fr/mesh/D017445?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Dermatoses vasculaires", "description": "Quels sont les principaux facteurs de risque ?\nLe tabagisme est-il un facteur de risque ?\nL'exposition au soleil influence-t-elle ces affections ?\nLe stress est-il un facteur de risque ?\nLes maladies chroniques augmentent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D017445?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on une dermatoses vasculaire ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique et parfois des biopsies cutanées." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les dermatoses vasculaires ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme l'échographie Doppler et l'angiographie peuvent être utilisés." } }, { "@type": "Question", "name": "Les dermatoses vasculaires nécessitent-elles des examens sanguins ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des examens sanguins peuvent être réalisés pour évaluer des troubles sous-jacents." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une dermatoses vasculaire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des rougeurs, des ecchymoses ou des lésions vasculaires visibles peuvent indiquer une affection." } }, { "@type": "Question", "name": "Peut-on confondre les dermatoses vasculaires avec d'autres maladies ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être confondues avec des maladies comme le psoriasis ou l'eczéma." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des dermatoses vasculaires ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des rougeurs, des démangeaisons, et des lésions cutanées." } }, { "@type": "Question", "name": "Les dermatoses vasculaires provoquent-elles des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent provoquer des douleurs, surtout si les lésions sont enflammées." } }, { "@type": "Question", "name": "Les dermatoses vasculaires peuvent-elles causer des saignements ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines peuvent entraîner des saignements, notamment les télangiectasies." } }, { "@type": "Question", "name": "Y a-t-il des symptômes systémiques associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la fièvre ou la fatigue peuvent survenir dans certains cas." } }, { "@type": "Question", "name": "Les démangeaisons sont-elles fréquentes ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les démangeaisons sont un symptôme fréquent des dermatoses vasculaires." } }, { "@type": "Question", "name": "Comment prévenir les dermatoses vasculaires ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les facteurs de risque comme l'exposition au soleil et le tabagisme peut aider." } }, { "@type": "Question", "name": "L'hydratation de la peau est-elle importante ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, maintenir la peau hydratée peut réduire le risque d'irritation et de lésions." } }, { "@type": "Question", "name": "Les vêtements peuvent-ils aider à prévenir ces affections ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, porter des vêtements protecteurs peut réduire l'exposition aux irritants." } }, { "@type": "Question", "name": "Faut-il éviter certains aliments ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Certaines personnes peuvent bénéficier d'un régime anti-inflammatoire pour réduire les symptômes." } }, { "@type": "Question", "name": "Le stress influence-t-il les dermatoses vasculaires ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut aggraver les symptômes, donc des techniques de gestion du stress sont utiles." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les dermatoses vasculaires ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des crèmes topiques, des lasers et parfois des médicaments oraux." } }, { "@type": "Question", "name": "Les corticostéroïdes sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les corticostéroïdes peuvent réduire l'inflammation et les symptômes cutanés." } }, { "@type": "Question", "name": "Quand faut-il envisager une intervention chirurgicale ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une intervention chirurgicale est envisagée pour les cas graves ou réfractaires aux traitements." } }, { "@type": "Question", "name": "Les traitements naturels sont-ils recommandés ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certains traitements naturels peuvent aider, mais il est important de consulter un médecin." } }, { "@type": "Question", "name": "Les lasers sont-ils efficaces pour traiter ces affections ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les lasers peuvent réduire l'apparence des lésions vasculaires et améliorer l'esthétique." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des infections ou des cicatrices peuvent survenir si non traitées." } }, { "@type": "Question", "name": "Les dermatoses vasculaires peuvent-elles affecter la qualité de vie ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner des problèmes psychologiques et affecter l'estime de soi." } }, { "@type": "Question", "name": "Y a-t-il un risque de cancer associé ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines dermatoses vasculaires peuvent avoir un risque accru de cancer cutané." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications ne sont pas fréquentes mais peuvent survenir dans des cas graves." } }, { "@type": "Question", "name": "Comment gérer les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des complications nécessite souvent une approche multidisciplinaire et un suivi régulier." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, le sexe féminin, et des antécédents familiaux de dermatoses." } }, { "@type": "Question", "name": "Le tabagisme est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut aggraver les dermatoses vasculaires et augmenter les symptômes." } }, { "@type": "Question", "name": "L'exposition au soleil influence-t-elle ces affections ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition excessive au soleil peut aggraver les dermatoses vasculaires." } }, { "@type": "Question", "name": "Le stress est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut exacerber les symptômes et augmenter le risque de dermatoses." } }, { "@type": "Question", "name": "Les maladies chroniques augmentent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies chroniques, comme le diabète, peuvent augmenter le risque de dermatoses." } } ] } ] }

Sources (10000 au total)

Design, Synthesis, Antibacterial Evaluation, Three-Dimensional Quantitative Structure-Activity Relationship, and Mechanism of Novel Quinazolinone Derivatives.

Plant bacterial illnesses are common and cause dramatic damage to agricultural goods all over the world, yet there are few efficient bactericides to alleviate them at present. To discover novel antiba...

Automated machine learning approach for developing a quantitative structure-activity relationship model for cardiac steroid inhibition of Na

Quantitative structure-activity relationship (QSAR) modeling is a method of characterizing the relationship between chemical structures and biological activity. Automated machine learning enables comp... The chemical structures and inhibitory activities of 215 CS derivatives were obtained from the scientific literature. Predictive QSAR models were constructed using molecular descriptors, fingerprints,... The best predictive QSAR models were selected based on the LogLoss value. Using these models, the Matthews correlation coefficient, F1 score, and area under the curve of the test dataset were 0.6729, ... The automated machine learning-based QSAR method developed here should be applicable for the time-efficient construction of predictive models using only a small number of compounds....

Multivariate image analysis applied to quantitative structure-activity relationships and docking studies of recent hydroxyphenylpyruvate deoxygenase inhibitors.

Mesotrione is a triketone widely used as an inhibitor of the hydroxyphenylpyruvate deoxygenase (HPPD) enzyme. However, new agrochemicals should be developed continuously to tackle the problem of herbi... The MIA-QSAR models based on van der Waals radii (r... Multivariate image analysis descriptors corroborated by docking studies were capable of modeling the herbicidal activities of 68 triketones reliably. Due to the substituent effects at the triketone fr...

Artificial Intelligence-Based Quantitative Structure-Property Relationship Model for Predicting Human Intestinal Absorption of Compounds with Serotonergic Activity.

Oral medicines represent the largest pharmaceutical market area. To achieve a therapeutic effect, a drug must penetrate the intestinal walls, the main absorption site for orally delivered active pharm...

Development of a quantitative structure-activity relationship model for predicting quantum yield of hydroxyl radical generation from organic compounds.

Organic compounds are capable of generating hydroxyl radicals (˙OH) through their excited triplet states in natural water. It is of significance to reveal the underlying mechanism of the generation an...

In vitro and Quantitative and Structure Activity Relationship (QSAR) evaluation of the antifungal activity of terpenoid constituents of essential oils against Alternaria alternata and Fusarium oxysporum

Fungal genera Alternaria and Fusarium include human and plant pathogenic species. Several antifungals have been used for their control, but excessive use has contributed to resistance development in p... To evaluate in vitro and in silico the antifungal activities of terpenoids against Alternaria alternata and Fusarium oxysporum.... The minimum inhibitory concentration and minimum fungicidal concentration values of 27 constituents of essential oils used against Alternaria alternata and Fusarium oxysporum were evaluated in vitro. ... The evaluated compounds proved to be effective antifungals. Thymol was the most active with a minimum inhibitory concentration of 91.6 ± 28.8 μg/ml for A. alternata and F. oxysporum. Quantitative stru... Terpenoids exhibit relevant antifungal activities that should be incorporated into the study of medicinal chemistry. Inclusion of in silico assays in the in vitro evaluation is a valuable tool in the ...

Three-dimensional quantitative structural-activity relationship and molecular dynamics study of multivariate substituted 4-oxyquinazoline HDAC6 inhibitors.

3D-QSAR models were established by collecting 46 multivariate-substituted 4-oxyquinazoline HDAC6 inhibitors. The relationship of molecular structure and inhibitory activity was studied by comparative ...

Identification of Potent Small-Molecule PCSK9 Inhibitors Based on Quantitative Structure-Activity Relationship, Pharmacophore Modeling, and Molecular Docking Procedure.

The leading cause of atherosclerotic cardiovascular disease (ASCVD) is elevated low-density lipoprotein cholesterol (LDL-C). Proprotein convertase subtilisin/kexin type 9 (PCSK9) attaches to the domai...

An Empirical Quantitative Structure-Activity Relationship Equation Assists the Discovery of High-Affinity Phosphodiesterase 4D Inhibitors as Leads to PET Radioligands.

A positron emission tomography (PET) radioligand for imaging phosphodiesterase 4D (PDE4D) would benefit drug discovery and the investigation of neuropsychiatric disorders. The most promising radioliga...